Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intervertebral disc extracellular matrix (IVD ECM) is a specialized, non-vascularized structural network that maintains the mechanical function and hydration of the spinal column [PubMed: 25643104]. It is primarily composed of a dense meshwork of Type II collagen fibers and large, sulfonated proteoglycans, most notably aggrecan, which create the osmotic pressure necessary for shock absorption [StatPearls: Intervertebral Disc Degeneration]. In the context of degenerative disc disease (DDD), the matrix undergoes a shift from an anabolic to a catabolic state, characterized by the upregulation of matrix metalloproteinases (MMPs) and ADAMTS enzymes that degrade these structural components [PubMed: 21658561]. Therapeutic interventions targeting the IVD ECM focus on restoring its integrity through the delivery of anabolic growth factors, inhibition of catabolic enzymes, or the use of biomimetic scaffolds. Because the disc is the largest avascular structure in the body, maintaining the health of the matrix is critical for nutrient diffusion and cell viability. Current research focuses on biological agents such as Growth Differentiation Factor 5 (GDF-5) and Link N peptide to stimulate endogenous repair of the matrix [PubMed: 23403567]. These interventions seek to reverse the pathological changes that contribute to chronic low back pain and spinal instability.
Stimulation of anabolic pathways in resident disc cells to increase the production of aggrecan and type II collagen, thereby restoring the structural and mechanical properties of the disc.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intervertebral disc extracellular matrix (IVD ECM) (IVD ECM).